Responses
Irritable bowel syndrome
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
Compose a Response to This Article
Other responses
No responses have been published for this article.